Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Targanta Therapeutics (TARG)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on TARG
Newest on TARG
Mark Cifra
(1)
Michael Becker
(1)
Andrew Waight
(1)
Mike Havrilla
(3)
SA Editor Abbi Adest
(1)
Most frequent on TARG
Mike Havrilla
(
3
)
SA Editor Abbi Adest
(
1
)
Andrew Waight
(
1
)
Michael Becker
(
1
)
Mark Cifra
(
1
)
Most followed on TARG
Mike Havrilla
(
1128
)
Michael Becker
(
76
)
SA Editor Abbi Adest
(
28
)
Mark Cifra
(
24
)
Most commented on TARG
Mike Havrilla
(
5
)
Mark Cifra
(
5
)
Andrew Waight
(
2
)
Michael Becker
(
1
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Targanta Therapeutics (TARG)
by
latest
|
most commented
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
CVTX
,
ARNA
,
ACOR
•
5 Comments
|
Quick Read
Bullish Thesis for Biotech Remains Intact
Feb 5
•
Michael Becker
•
ALPMF.PK
,
BMRN
,
ANDS
•
1 Comment
|
Quick Read
Updated FDA Calendar: Cypress Bioscience Looks Like a Buy
Dec 12, 2008
•
Mike Havrilla
•
ALKS
,
ALO
,
ACUS
•
1 Comment
|
Quick Read
Three-Month, Updated FDA Decision Calendar
Dec 1, 2008
•
Mike Havrilla
•
AMGN
,
GENZ
,
JNJ
•
Comment!
|
Quick Read
73 Decision Dates on Updated FDA Calendar
Nov 22, 2008
•
Mike Havrilla
•
ISTA
,
AMGN
,
GSK
•
4 Comments
|
Quick Read
The Long Case for Targanta Therapeutics
Jan 31, 2008
•
Andrew Waight
•
CBST
,
TARG
,
THRX
•
2 Comments
|
Quick Read
This Week's IPOs: Affinion Group Holdings, Compellent Technologies, EyeTel Imaging, Targanta Therapeutics, Textainer Group Holdings, Virgin Mobile USA, BioHeart
Oct 7, 2007
•
SA Editor Abbi Adest
•
CML
,
AFI
,
BHRT
•
Comment!
|
Quick Read